These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23786722)

  • 1. Cholinesterase inhibitors in vascular cognitive impairment.
    Massoud F
    Can J Neurol Sci; 2013 Jul; 40(4):446-7. PubMed ID: 23786722
    [No Abstract]   [Full Text] [Related]  

  • 2. Realizing early treatment benefits in dementia.
    Gauthier SG
    Eur J Neurol; 2005 Oct; 12 Suppl 3():1-2. PubMed ID: 16144530
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
    Alagiakrishnan K; Sclater A; Robertson D
    J Am Geriatr Soc; 2003 Sep; 51(9):1326. PubMed ID: 12919253
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs and vascular dementia.
    Allain H; Bentue-Ferrer D; Tribut O; Pinel JF
    Dement Geriatr Cogn Disord; 2003; 16(1):1-6. PubMed ID: 12714793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine for vascular dementia: some answers, some questions.
    Schneider LS
    Lancet; 2002 Apr; 359(9314):1265-6. PubMed ID: 11965268
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel treatment for patients with Alzheimer's disease and with vascular dementia.
    Kurz A
    Ann N Y Acad Sci; 2002 Nov; 977():476-81. PubMed ID: 12480788
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for vascular dementia.
    Korczyn AD
    Lancet Neurol; 2007 Sep; 6(9):749-51. PubMed ID: 17706553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Zharikov GA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262
    [No Abstract]   [Full Text] [Related]  

  • 9. Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine.
    Lilienfeld S; Kurz A
    Ann N Y Acad Sci; 2002 Nov; 977():487-92. PubMed ID: 12480790
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinesterase inhibitors: drugs looking for a disease?
    Maggini M; Vanacore N; Raschetti R
    PLoS Med; 2006 Apr; 3(4):e140. PubMed ID: 16597173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
    Bowler JV
    Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
    [No Abstract]   [Full Text] [Related]  

  • 14. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are cholinesterase inhibitors more than symptomatic treatments for Alzheimer disease?
    Relkin N
    Alzheimer Dis Assoc Disord; 2006; 20(2 Suppl 1):S2. PubMed ID: 16772753
    [No Abstract]   [Full Text] [Related]  

  • 16. Dementia: it's not just about Alzheimer's. Other distinct forms exist.
    Miller B
    Health News; 2003 Sep; 9(9):4. PubMed ID: 14584467
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differentiating between Alzheimer disease and vascular dementia? Currently no longer significant].
    Wettstein A
    Fortschr Med Orig; 2001 Nov; 119(3-4):139-40. PubMed ID: 11789126
    [No Abstract]   [Full Text] [Related]  

  • 18. [To differentiate Alzheimer's and vascular dementia? Today no longer up to date].
    Wettstein A
    MMW Fortschr Med; 2001 Dec; 143(51-52):41-2. PubMed ID: 11824166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of dementia].
    Blom K; van den Elsen GAH; Koek HL; Sanders JB; Kruithof HC; Claassen JAHR
    Ned Tijdschr Geneeskd; 2017; 161():D1851. PubMed ID: 28936936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.